aTyr Pharma Inc.
(ATYR)
undefined
undefined%
At close: undefined
4.02
0.88%
After-hours Jan 03, 2025, 05:40 PM EST
Company Description
No Company description available at the moment.
aTyr Pharma Inc.
| Country | n/a |
| IPO Date | n/a |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 56 |
| CEO | Dr. Sanjay S. Shukla M.D., M.S. |
Contact Details
Address: No Address available No city data available, | |
| Website | n/a |
Stock Details
| Ticker Symbol | n/a |
| Exchange | NASDAQ |
| Fiscal Year | n/a |
| Reporting Currency | USD |
| CIK Code | n/a |
| CUSIP Number | n/a |
| ISIN Number | US0021202025 |
| Employer ID | - |
| SIC Code | n/a |
Key Executives
| Name | Position |
|---|---|
| Dr. Sanjay S. Shukla M.D., M.S. | President, Chief Executive Officer & Director |
| Jill M. Broadfoot CPA | Chief Financial Officer |
| Ashlee Dunston | Director of Investor Relations & Corporate Communications |
| Danielle Campbell | Vice President of Human Resource |
| Dr. Jayant Aphale MBA, Ph.D. | Vice President of Technical Operations |
| Dr. Leslie Nangle Ph.D. | Vice President of Research |
| Dr. Ying J. Buechler Ph.D. | Executive Director of Biologics Development & Manufacturing |
| Nancy E. Denyes Krueger J.D. | General Counsel & Corporate Secretary |
| Peter Villiger | Vice President of Corporate Development |
| Xiang-Lei Yang Ph.D. | Founder |